Also trades as: DRMAW (NASDAQ) · $vol 0M
DRMA NASDAQ
Dermata Therapeutics, Inc.
1W: -4.8%
1M: -11.9%
3M: -7.8%
YTD: -45.9%
1Y: +49.2%
3Y: -97.0%
$1.18
-0.02 (-1.67%)
Pre-Market: $1.19 (+0.01, +1.27%)
Weekly Expected Move ±7.2%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Last Earnings
2026-03-26
EPS
$-1.52
▲ Beat +1.3%
Revenue
—
Next Earnings
2026-08-18
EPS Estimate
$-0.57
Range: $-0.57 - $-0.57
Estimate vs Actual
Earnings Surprise History
4/18
EPS Beats
0/18
Revenue Beats
22%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-04-08 | quarter | 2026-06-30 | $-0.84 | $-0.57 | ▲ 0.27 | $— | $— |
| 2026-04-08 | quarter | 2026-09-30 | $-0.84 | $-0.61 | ▲ 0.23 | $— | $25,000 |
| 2026-04-08 | quarter | 2026-12-31 | $-0.65 | $-0.50 | ▲ 0.15 | $— | $75,000 |
| 2026-04-08 | annual | 2026-12-31 | $-3.01 | $-2.20 | ▲ 0.81 | $15,000,000 | $100,000 |
| 2026-04-08 | quarter | 2026-03-31 | $-0.72 | $-0.53 | ▲ 0.19 | $— | $— |
| 2026-04-06 | annual | 2027-12-31 | $-1.49 | $-1.49 | — | $750 | $750,000 |
| 2026-04-03 | annual | 2027-12-31 | $— | $-1.49 | ▼ 1.49 | $— | $750 |
| 2026-03-30 | quarter | 2026-12-31 | $— | $-0.65 | ▼ 0.65 | $— | $— |
| 2026-03-30 | quarter | 2026-03-31 | $— | $-0.72 | ▼ 0.72 | $— | $— |
| 2026-03-30 | quarter | 2025-12-31 | $— | $-1.54 | ▼ 1.54 | $— | $— |
Earnings Call Transcripts
No transcripts available.